Aging-Related Calcium Dysregulation in Rat Entorhinal Neurons Homologous with the Human Entorhinal Neurons in which Alzheimer's Disease Neurofibrillary Tangles First Appear

被引:7
|
作者
Gant, John C. [1 ]
Kadish, Inga [2 ]
Chen, Kuey-Chu [1 ]
Thibault, Olivier [1 ]
Blalock, Eric M. [1 ]
Porter, Nada M. [1 ]
Landfield, Philip W. [1 ]
机构
[1] Univ Kentucky, Dept Pharmacol & Nutr Sci, 800 Rose St,UKMC MS 307, Lexington, KY 40536 USA
[2] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA
关键词
Afterhyperpolarization; aging models; calcium-dependent; cytoskeleton; FKBP; hippocampus; neurofibrillary progression; ryanodine receptor; FK506-BINDING PROTEIN 12.6/1B; ANIMAL-MODELS; HIPPOCAMPAL-NEURONS; DENTATE GYRUS; MOUSE MODEL; CORTEX; BRAIN; CELLS; CA2+; PROJECTIONS;
D O I
10.3233/JAD-180618
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aging is the leading risk factor for idiopathic Alzheimer's disease (AD), indicating that normal aging processes promote AD and likely are present in the neurons in which AD pathogenesis originates. In AD, neurofibrillary tangles (NFTs) appear first in entorhinal cortex, implying that aging processes in entorhinal neurons promote NFT pathogenesis. Using electrophysiology and immunohistochemistry, we find pronounced aging-related Ca2+ dysregulation in rat entorhinal neurons homologous with the human neurons in which NFTs originate. Considering that humans recapitulate many aspects of animal brain aging, these results support the hypothesis that aging-related Ca2+ dysregulation occurs in human entorhinal neurons and promotes NFT pathogenesis.
引用
收藏
页码:1371 / 1378
页数:8
相关论文
共 1 条
  • [1] Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease
    Llamas-Rodriguez, Josue
    Oltmer, Jan
    Greve, Douglas N.
    Williams, Emily
    Slepneva, Natalya
    Wang, Ruopeng
    Champion, Samantha
    Lang-Orsini, Melanie
    Fischl, Bruce
    Frosch, Matthew P.
    van der Kouwe, Andre J. W.
    Augustinack, Jean C.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (03) : 1379 - 1399